Confo Therapeutics appoints Galapagos veteran as CSO

May 10, 2016 News Quality by Design - Business & Communications

VIB/VUB spin-off Confo Therapeutics has appointed Dr. Christel Menet as its new Chief Scientific Officer. Menet previously held the position of Director of Chemistry at biotech heavyweight Galapagos, where she was responsible for the full development of the company’s most advanced and successful molecule filgotinib. The JAK1 inhibitor, which has proven to be effective in both Crohn’s disease and rheumatoid arthritis, is currently preparing for phase III clinical trials.

“I am thrilled to join Confo Therapeutics at an exciting time, and am impressed by the broad applicability of the break-through CONFO® technology. It allows medically relevant GPCRs to be stabilized in their active signaling state, revealing new binding pockets accessible for drug discovery. I’m looking forward to contribute to the selection and direction of Confo Therapeutics’ pipeline candidates”, said Dr. Christel Menet.

GPCRs are attractive drug targets since they are involved in many essential cellular processes and diseases. By stabilizing the receptors with the CONFO® technology, GPCR that are currently considered undruggable can be targeted. This opens up treatment possibilities for diseases with high unmet medical needs.

More information at

Avatar photo
Quality by Design - Business & Communications

Quality by Design (QbD) - Business & Communications is a team of expert strategists, scientists, communicators, and creatives. Whether you're a part of an innovative startup or an established player, our unique approach will ensure that your company has the best chance of being seen and understood by your target audience: prospects, clients, investors, partners, and more. We don’t just consult; we also help you implement. We share articles on BioVox providing insight into new and established players in the Benelux Life Science ecosystem, from innovations and research breakthroughs through to finance and industry trends.

All posts


* indicates required

Intuit Mailchimp